Cyclizine Lactate
Generic Name: cyclizine lactate
Manufactured by GLAXOSMITHKLINE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CYCLIZINE LACTATE (50MG/ML). Application: NDA009495.
Overview
Manufactured by GLAXOSMITHKLINE. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: CYCLIZINE LACTATE (50MG/ML). Application: NDA009495.
Dosage
Available as injectable for injection use.
Related Medications
Isosulfan Blue
isosulfan blue
11 DESCRIPTION The chemical name of isosulfan blue is N-[4-[[4-(diethylamino)phenyl] (2,5-disulfophenyl) methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium hydroxide, inner salt, sodium salt. Isosulfan blue is a greenish blue color hygroscopic powder. Its structural formula is: Isosulfan blue injection 1% is a sterile, non-pyrogenic, aqueous dark blue color solution for subcutaneous administration.
Lemborexant
lemborexant
Orexin Receptor Antagonist [EPC]
11 DESCRIPTION DAYVIGO contains lemborexant, an orexin receptor antagonist. The chemical name of lemborexant is (1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)- N -(5-fluoropyridin-2-yl) cyclopropanecarboxamide. The molecular formula is C 22 H 20 F 2 N 4 O 2 . The molecular weight is 410.42. The structural formula is: Lemborexant is a white to off-white powder that is practically insoluble in water. DAYVIGO tablets are intended for oral administration.
Onasemnogene Abeparvovec-brve
onasemnogene abeparvovec-brve
11 DESCRIPTION ITVISMA (onasemnogene abeparvovec-brve) is a suspension of an adeno-associated viral vector-based gene therapy for intrathecal injection. It is a recombinant self-complementary AAV9 containing a transgene encoding the human survival motor neuron (SMN) protein, under the control of a cytomegalovirus enhancer/chickenβactin hybrid promoter. ITVISMA has a nominal concentration of 4 × 10 13 vg/mL.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.